Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity buys Pathway Medical for  million to help doctors get AI-powered answers


Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.

Source: NYSE

Doximity is diving deeper into artificial intelligence, announcing on Thursday the acquisition of startup Pathway Medical for $63 million. 

Pathway has built an AI-powered clinical reference tool that doctors can use to ask questions about guidelines, drugs and trials. Pathway’s answers are synthesized from medical literature, and Doximity said the Montreal-based startup has one of the largest structured datasets in medicine. 

Doximity’s platform, which for years was described as LinkedIn for doctors, helps clinicians stay current on medical news, manage paperwork, find referrals and carry out telehealth appointments with patients. Through its acquisition of Pathway, Doximity hopes doctors will also turn to the platform to answer their clinical questions.

“We hunted high and low, and I think we found the best company in the space at answering physicians’ questions using AI, and it wasn’t in Silicon Valley,” Jeff Tangney, Doximity’s co-founder and CEO, told CNBC in an interview. 

The deal closed in late July for a cash consideration of $26 million and up to $37 million in additional equity grants, Doximity said. 

Doximity’s integration with Pathway is well underway, Tangney said, and the companies are testing a combined product with thousands of doctors. 

Doximity already has a free AI product, Doximity GPT, that doctors can use to generate insurance letters and summarize patient charts and reports. Pathway will bring additional “robustness” to the data that Doximity has on the back end, said Dr. Amit Phull, Doximity’s chief clinical experience officer.  

“What Pathway brings to this party or this marriage is that they have a very, very robust back-end data set that ties dosages to guidelines to literature to citations,” Phull told CNBC in an interview. 

Pathway’s model scored 96% on the U.S. Medical Licensing Examination benchmark, Doximity said, which doctors have to take to prove that they understand and can apply medical knowledge.

Doximity, which went public in 2021, has seen its stock climb 8% this year after soaring 90% in 2024. The company has a market cap of about $11 billion.

Doximity is holding its quarterly conference call with investors to discuss its fiscal first-quarter results on Thursday at 5 p.m. ET. 



Source

CNBC Daily Open: The AI industry’s ‘happy few’ 
World

CNBC Daily Open: The AI industry’s ‘happy few’ 

Companies touting their artificial intelligence products dominated the Promenade, the main road in Davos. In past years at the World Economic Forum annual meeting, cryptocurrency firms were the most prominent down the Promenade. But AI fever has taken over in 2024. Arjun Kharpal | CNBC “We few, we happy few, we band of brothers.” The […]

Read More
Staffing issues cause delays at U.S. airports as shutdown persists
World

Staffing issues cause delays at U.S. airports as shutdown persists

Sean Duffy, U.S. secretary of transportation, during a news conference in Terminal A at Newark Liberty International Airport (EWR) in Newark, New Jersey, US, on Monday, Oct. 6, 2025. Michael Nagle | Bloomberg | Getty Images The Federal Aviation Administration said staffing issues were causing delays at several airports, including Newark and Denver, on Monday, […]

Read More
Asia-Pacific markets set to open mixed, following Wall Street gains on AMD rally
World

Asia-Pacific markets set to open mixed, following Wall Street gains on AMD rally

Aerial view by drone of Tokyo Cityscape with Tokyo Sky Tree visible in Tokyo city, Japan on sunrise. pongnathee kluaythong | Moment | Getty Images Asia-Pacific markets were set to open mostly higher Tuesday, tracking Wall Street gains on a tech rally fueled by the massive deal between OpenAI and AMD, in one of the […]

Read More